Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

NCT05158387 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1172

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Tozorakimab
DRUG: Tozorakimab
DRUG: Placebo

Sponsor

AstraZeneca